Search results
Found 2375 matches for
The University of Oxford has today announced an agreement with the UK-based global biopharmaceutical company AstraZeneca for the further development, large-scale manufacture and potential distribution of the COVID-19 vaccine candidate currently being trialled by the Oxford Vaccine Group.
Research
The Oxford Vaccine Group conducts laboratory and clinical research in many different areas related to infectious diseases and vaccination in childhood as well as adulthood. Below you can browse all the different areas we investigate.
Study with us
We are committed to providing high quality education and training, together with research updates for medical professionals and all those involved in the area of vaccines and paediatric and adult infectious diseases.